| P50 | author | Gommert van Koeveringe | Q92235346 |
| P2093 | author name string | Ruth Achten | |
| | Philip van Kerrebroeck | |
| | Koenraad van Renterghem | |
| P2860 | cites work | Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease | Q24632629 |
| | Complications of transurethral resection of the prostate (TURP)--incidence, management, and prevention | Q33233565 |
| | Techniques and long-term results of surgical procedures for BPH. | Q33234047 |
| | A tomato-based, lycopene-containing intervention for androgen-independent prostate cancer: results of a Phase II study from the North Central Cancer Treatment Group | Q33436746 |
| | Prostate specific antigen and benign prostatic hyperplasia | Q33825838 |
| | Asymptomatic inflammation and/or infection in benign prostatic hyperplasia | Q33881269 |
| | DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer | Q34206957 |
| | PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy | Q34611796 |
| | PCA3: a molecular urine assay for predicting prostate biopsy outcome | Q34754205 |
| | Clinical utility of the PCA3 urine assay in European men scheduled for repeat biopsy | Q34792453 |
| | The clinical assessment of benign prostatic hyperplasia | Q35321380 |
| | Late renal failure due to prostatic outflow obstruction: a preventable disease | Q35707598 |
| | Health perceptions in patients who undergo screening and workup for prostate cancer | Q35792722 |
| | Is benign prostatic hyperplasia a risk factor for chronic renal failure? | Q36042083 |
| | Value of contrast-enhanced ultrasound and elastography in imaging of prostate cancer | Q36672539 |
| | Dietary intervention in the management of prostate cancer | Q36783669 |
| | PSA and other tissue kallikreins for prostate cancer detection | Q36906058 |
| | Extended and saturation prostatic biopsy in the diagnosis and characterisation of prostate cancer: a critical analysis of the literature | Q36919452 |
| | Contrast-enhanced ultrasound for diagnosis of prostate cancer and kidney lesions | Q36946238 |
| | Imaging and estimation of tissue elasticity by ultrasound | Q37036662 |
| | Prostate cancer diagnosis: value of real-time elastography | Q37057354 |
| | Local progression among men with conservatively treated localized prostate cancer: results from the Transatlantic Prostate Group | Q37107552 |
| | MR-guided biopsy of the prostate: an overview of techniques and a systematic review | Q37197406 |
| | Contrast-enhanced ultrasound and prostate cancer; a multicentre European research coordination project | Q37201681 |
| | Clinical utility of proPSA and "benign" PSA when percent free PSA is less than 15%. | Q38444886 |
| | Influence of finasteride on free and total serum prostate specific antigen levels in men with benign prostatic hyperplasia | Q38471668 |
| | Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. | Q39278530 |
| | Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening | Q39372130 |
| | Indications for ultrasound guided transition zone biopsies in the detection of prostate cancer | Q39386098 |
| | Does transurethral resection of the prostate facilitate detection of clinically significant prostate cancer that is missed with systematic sextant and transition zone biopsies? | Q39406678 |
| | Value of systematic transition zone biopsies in the early detection of prostate cancer | Q39418166 |
| | Urodynamic pressure flow studies can predict the clinical outcome after transurethral prostatic resection | Q39422560 |
| | Age specific prostate specific antigen reference ranges: population specific | Q39470176 |
| | Extended sector biopsy for detection of carcinoma of the prostate | Q39566630 |
| | Improving prostate cancer detection with an extended-core transrectal ultrasonography-guided prostate biopsy protocol | Q39594375 |
| | Detection of prostate cancer and changes in prostate-specific antigen (PSA) six months after surgery for benign prostatic hyperplasia in patients with elevated PSA. | Q39656362 |
| | Detection of prostate cancer by TURP or open surgery in patients with previously negative transrectal prostate biopsies | Q39669498 |
| | A prospective study of lycopene and tomato product intake and risk of prostate cancer | Q39743293 |
| | The time-resolved fluorescence-based PCA3 test on urinary sediments after digital rectal examination; a Dutch multicenter validation of the diagnostic performance | Q39786063 |
| | Extended 21-sample needle biopsy protocol for diagnosis of prostate cancer in 1000 consecutive patients | Q39792720 |
| | Rising PSA in patients with minor LUTS without evidence of prostatic carcinoma: a missing link? | Q39802969 |
| | The utility of transrectal real-time elastography in the diagnosis of prostate cancer | Q39832968 |
| | Prospective study of the role of transurethral resection of the prostate in patients with an elevated prostate-specific antigen level, minor lower urinary tract symptoms, and proven bladder outlet obstruction | Q39852069 |
| | Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program | Q40570983 |
| | Serum prostate specific antigen is a strong predictor of future prostate growth in men with benign prostatic hyperplasia. PROSCAR long-term efficacy and safety study | Q40785798 |
| | Reoperation, myocardial infarction and mortality after transurethral and open prostatectomy: a nation-wide, long-term analysis of 23,123 cases | Q42651016 |
| | Predictors of cancer progression in T1a prostate adenocarcinoma | Q45227887 |
| | Economic costs of benign prostatic hyperplasia in the private sector. | Q45993292 |
| | Routine transition zone and seminal vesicle biopsies in all patients undergoing transrectal ultrasound guided prostate biopsies are not indicated. | Q46040155 |
| | Evaluation of prostate cancer detection with ultrasound real-time elastography: a comparison with step section pathological analysis after radical prostatectomy. | Q47830737 |
| | Repeated negative prostate biopsies with persistently elevated or rising PSA: a modern urologic dilemma. | Q50903311 |
| | False-positive findings in mammography screening induces short-term distress - breast cancer-specific concern prevails longer. | Q51080127 |
| | Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging. | Q52075910 |
| | Prognostic role of prostate-specific antigen and prostate volume for the risk of invasive therapy in patients with benign prostatic hyperplasia initially managed with alpha1-blockers and watchful waiting | Q57307267 |
| | Prostate Specific Antigen Velocity Threshold for Predicting Prostate Cancer in Young Men | Q59563510 |
| | Effect of finasteride and/or terazosin on serum PSA: results of VA Cooperative Study #359. | Q64972800 |
| | The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen | Q67532196 |
| | Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate | Q69003522 |
| | Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate | Q71927028 |
| | Indications for transition zone biopsy in the detection of prostatic carcinoma | Q71975825 |
| | Preoperative urodynamic and symptom evaluation of patients undergoing transurethral prostatectomy: analysis of variables relevant for outcome | Q73042172 |
| | Standardization of terminology of lower urinary tract function: pressure-flow studies of voiding, urethral resistance, and urethral obstruction. International Continence Society Subcommittee on Standardization of Terminology of Pressure-Flow Studies | Q73042719 |
| | The impact of abnormal mammograms on psychosocial outcomes and subsequent screening | Q73094002 |
| | Transurethral biopsy of the prostate for persistently elevated or increasing prostate specific antigen following multiple negative transrectal biopsies | Q73422455 |
| | Effect of inflammation and benign prostatic enlargement on total and percent free serum prostatic specific antigen | Q73676486 |
| | Optimal combinations of systematic sextant and laterally directed biopsies for the detection of prostate cancer | Q73850923 |
| | Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: when should we stop? | Q74591846 |
| | Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia. PLESS Study Group | Q74650177 |
| | Benign prostate-specific antigen (BPSA) in serum is increased in benign prostate disease | Q78863347 |
| | Dietary manipulation, ethnicity, and serum psa levels | Q79149065 |
| | Computer simulated additional deep apical biopsy enhances cancer detection in palpably benign prostate gland | Q79160489 |
| | Is the short-term outcome of transurethral resection of the prostate affected by preoperative degree of bladder outlet obstruction, status of detrusor contractility or detrusor overactivity? | Q79327781 |
| | Methods of calculating prostate-specific antigen velocity | Q79465127 |
| | Large-scale study of clinical impact of PSA velocity: long-term PSA kinetics as method of differentiating men with from those without prostate cancer | Q79707664 |
| | Peri-operative morbidity and changes in symptom scores after transurethral prostatectomy in Switzerland: results of an independent assessment of outcome | Q80032899 |
| | Clinical relevance of transurethral resection of the prostate in "asymptomatic" patients with an elevated prostate-specific antigen level | Q80120947 |
| | BPSA: A Novel Serum Marker for Benign Prostatic Hyperplasia | Q80297430 |
| | Targeted biopsy of the prostate: the impact of color Doppler imaging and elastography on prostate cancer detection and Gleason score | Q80404957 |
| | Role of transition zone sampling by TURP in patients with raised PSA and multiple negative transrectal ultrasound-guided prostatic biopsies | Q80559394 |
| | Are repeat biopsies required in men with PSA levels < or =4 ng/ml? A Multiinstitutional Prospective European Study | Q81102301 |
| | Serum prostate-specific antigen to predict the presence of bladder outlet obstruction in men with urinary symptoms | Q81174208 |
| | Importance of TURP in diagnosing prostate cancer in men with multiple negative biopsies | Q81403595 |
| | Improvement in mortality and morbidity in transurethral resection of the prostate over 17 years in a single center | Q81452186 |
| | Reassessing the diagnostic yield of saturation biopsy of the prostate | Q81587172 |
| | Enhancement characteristics of benign and malignant focal peripheral nodules in the peripheral zone of the prostate gland studied using contrast-enhanced transrectal ultrasound | Q81935608 |
| | Comparison of the clinical value of complexed PSA and total PSA in the discrimination between benign prostatic hyperplasia and prostate cancer | Q82215204 |
| | Role of transurethral resection of the prostate and biopsy of the peripheral zone in the same session after repeated negative biopsies in the diagnosis of prostate cancer | Q82385531 |
| | The difficult case in prostate cancer diagnosis--when is a "diagnostic TURP" indicated? | Q82467516 |
| | An evaluation of the economic costs and patient-related consequences of treatments for benign prostatic hyperplasia | Q82853544 |
| | Is chronic inflammatory change in the prostate the major cause of rising serum prostate-specific antigen in patients with clinical suspicion of prostate cancer? | Q82963141 |
| | Analysis of prognostic factors regarding the outcome after a transurethral resection for symptomatic benign prostatic enlargement | Q83835691 |
| | Long-term clinical outcome of diagnostic transurethral resection of the prostate in patients with elevated prostate-specific antigen level and minor lower urinary tract symptoms | Q84313781 |
| P275 | copyright license | Creative Commons Attribution-NonCommercial 4.0 International | Q34179348 |
| P433 | issue | 1 | |
| P921 | main subject | biopsy | Q179991 |
| | Kallikrein related peptidase 3 | Q409450 |
| | algorithm | Q8366 |
| | prostatic hypertrophy | Q506659 |
| | prostatism | Q67517771 |
| P304 | page(s) | 29-38 | |
| P577 | publication date | 2009-06-03 | |
| | 2010-03-01 | |
| P1433 | published in | International Urology and Nephrology | Q15763616 |
| P1476 | title | A new algorithm in patients with elevated and/or rising prostate-specific antigen level, minor lower urinary tract symptoms, and negative multisite prostate biopsies | |
| P478 | volume | 42 | |